Aging, testosterone and male fertility therapy: a review

Men’s fertility declines as they age. Reduced reproductive function lowers testosterone levels, which leads to poor sperm quality and low fertility. This article summarizes the decline in male fertility and reproductive functions with age and highlights the relationship between aging and testosterone. It also examines various testosterone-based health treatments that can improve male fertility. A systematic search was conducted in five databases, including PubMed, SCOPUS, Google Scholar, Web of Science and EMBASE. The search terms included “male aging”, “male fertility”, “male fertility treatment”, “testosterone” and “fertility treatment”. We systematically reviewed primary English-language studies, including peer-reviewed and non-peer-reviewed sources, while excluding samples, reviews, internet articles, editorials, protocols, perspectives, commentaries, publications, reports and non-primary data. We also manually searched reference lists. It was observed that testosterone impacts male virility, physical and mental health, and the aging process. Novel therapeutic approaches, such as the use of natural product-derived pharmacologic therapies are required to maintain healthy gonadal function, or enhanced reactive oxygen species (ROS) scavenging and sperm quality while considering gene and DNA repair.

Male aging; Male fertility; Testosterone; Male reproduction

[1] Ketchem JM, Bowman EJ, Isales CM. Male sex hormones, aging, and inflammation. Biogerontology. 2023; 24: 1–25.

[2] Meyer RG, Meyer-Ficca ML. Metabolism in male reproductive aging. Advances in Geriatric Medicine and Research. 2021; 3: e210005.

[3] Gunes S, Hekim GNT, Arslan MA, Asci R. Effects of aging on the male reproductive system. Journal of Assisted Reproduction and Genetics. 2016; 33: 441–454.

[4] Matzkin ME, Calandra RS, Rossi SP, Bartke A, Frungieri MB. Hallmarks of testicular aging: the challenge of anti-inflammatory and antioxidant therapies using natural and/or pharmacological compounds to improve the physiopathological status of the aged male gonad. Cells. 2021; 10: 3114.

[5] Nieschlag E. Late‐onset hypogonadism: a concept comes of age. Andrology. 2020; 8: 1506–1511.

[6] Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology. 2021; 22: 119–141.

[7] McReynolds MR, Chellappa K, Baur JA. Age-related NAD+ decline. Experimental Gerontology. 2020; 134: 110888.

[8] Xie N, Zhang L, Gao W, Huang C, Huber PE, Zhou X, et al. NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential. Signal Transduction and Targeted Therapy. 2020; 5: 227.

[9] Bradshaw PC. Cytoplasmic and mitochondrial NADPH-coupled redox systems in the regulation of aging. Nutrients. 2019; 11: 504.

[10] Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology. 2021; 22: 119–141.

[11] Shirakawa T, Fink J, Hotta Z, Shimada Y, Lu Y, Du J, et al. The impact of serum testosterone level to reflect age-related multi-organ functions. Endocrine Journal. 2024; 71: 265–272.

[12] Blagosklonny MV. Are menopause, aging and prostate cancer diseases? Aging. 2022; 15: 298–307.

[13] Park YJ, Pang MG. Mitochondrial functionality in male fertility: from spermatogenesis to fertilization. Antioxidants. 2021; 10: 98.

[14] Costa J, Braga PC, Rebelo I, Oliveira PF, Alves MG. Mitochondria quality control and male fertility. Biology. 2023; 12: 827.

[15] Osellame LD, Blacker TS, Duchen MR. Cellular and molecular mechanisms of mitochondrial function. Best Practice & Research Clinical Endocrinology & Metabolism. 2012; 26: 711–723.

[16] Vernochet C, Damilano F, Mourier A, Bezy O, Mori MA, Smyth G, et al. Adipose tissue mitochondrial dysfunction triggers a lipodystrophic syndrome with insulin resistance, hepatosteatosis, and cardiovascular complications. The FASEB Journal. 2014; 28: 4408–4419.

[17] Costa J, Braga PC, Rebelo I, Oliveira PF, Alves MG. Mitochondria quality control and male fertility. Biology. 2023; 12: 827.

[18] Aitken RJ, Drevet JR. The importance of oxidative stress in determining the functionality of mammalian spermatozoa: a two-edged sword. Antioxidants. 2020; 9: 111.

[19] Costa J, Braga PC, Rebelo I, Oliveira PF, Alves MG. Mitochondria quality control and male fertility. Biology. 2023; 12: 827.

[20] Minas A, Fernandes ACC, Maciel Júnior VL, Adami L, Intasqui P, Bertolla RP. Influence of physical activity on male fertility. Andrologia. 2022; 54: e14433.

[21] Yeap BB, Flicker L. Testosterone, cognitive decline and dementia in ageing men. Reviews in Endocrine and Metabolic Disorders. 2022; 23: 1243–1257.

[22] Ide H. The impact of testosterone in men’s health. Endocrine Journal. 2023; 70: 655–662.

[23] Corona G, Filippi S, Comelio P, Bianchi N, Frizza F, Dicuio M, et al. Sexual function in men undergoing androgen deprivation therapy. International Journal of Impotence Research. 2021; 33: 439–447.

[24] Zhong SR, Yang HH, Liao CH, Yang DH, Tu SK, Hung CL, et al. Association between low serum testosterone and the development of metabolic syndrome in elderly Taiwanese men. Diabetes, Metabolic Syndrome and Obesity. 2021; 14: 99–106.

[25] Kanabar R, Mazur A, Plum A, Schmied J. Correlates of testosterone change as men age. The Aging Male. 2022; 25: 29–40.

[26] Figueiredo MG, Gagliano-Jucá T, Basaria S. Male reproduction and aging. Endocrinology and Metabolism Clinics of North America. 2023; 52: 211–228.

[27] Salonia A, Bettocchi C, Boeri L, Capogrosso P, Carvalho J, Cilesiz NC, et al. European association of urology guidelines on sexual and reproductive health—2021 update: male sexual dysfunction. European Urology. 2021; 80: 333–357.

[28] Genchi VA, Rossi E, Lauriola C, D’Oria R, Palma G, Borrelli A, et al. Adipose tissue dysfunction and obesity-related male hypogonadism. International Journal of Molecular Sciences. 2022; 23: 8194.

[29] George BT, Jhancy M, Dube R, Kar SS, Annamma LM. The molecular basis of male infertility in obesity: a literature review. International Journal of Molecular Sciences. 2023; 25: 179.

[30] Wittert G, Grossmann M. Obesity, type 2 diabetes, and testosterone in ageing men. Reviews in Endocrine and Metabolic Disorders. 2022; 23: 1233–1242.

[31] Nguyen Hoai B, Hoang L, Nguyen Cao T, Pham Minh Q, A. Jannini E. Testosterone and aging male, a perspective from a developing country. The Aging Male. 2023; 26: 2223712.

[32] Tam BT, Morais JA, Santosa S. Obesity and ageing: two sides of the same coin. Obesity Reviews. 2020; 21: e12991.

[33] Luo D, Qi X, Xu X, Yang L, Yu C, Guan Q. Involvement of p38 MAPK in Leydig cell aging and age-related decline in testosterone. Frontiers in Endocrinology. 2023; 14: 1088249.

[34] Franzago M, Pilenzi L, Di Rado S, Vitacolonna E, Stuppia L. The epigenetic aging, obesity, and lifestyle. Frontiers in Cell and Developmental Biology. 2022; 10: 985274.

[35] Ki Y, Park JH, Lee JE, Shin IC, Koh HC. JNK and p38 MAPK regulate oxidative stress and the inflammatory response in chlorpyrifos-induced apoptosis. Toxicology Letters. 2013; 218: 235–245.

[36] Marioni RE, Harris SE, Shah S, McRae AF, von Zglinicki T, Martin-Ruiz C, et al. The epigenetic clock and telomere length are independently associated with chronological age and mortality. International Journal of Epidemiology. 2016; 45: 424–432.

[37] Schumacher B, Pothof J, Vijg J, Hoeijmakers JHJ. The central role of DNA damage in the ageing process. Nature. 2021; 592: 695–703.

[38] Samarghandian S, Azimi‐Nezhad M, Farkhondeh T. Thymoquinone‐induced antitumor and apoptosis in human lung adenocarcinoma cells. Journal of Cellular Physiology. 2019; 234: 10421–10431.

[39] Kohandel Z, Farkhondeh T, Aschner M, Pourbagher-Shahri AM, Samarghandian S. Anti-inflammatory action of astaxanthin and its use in the treatment of various diseases. Biomedicine & Pharmacotherapy. 2022; 145: 112179.

[40] Monageng E, Offor U, Takalani NB, Mohlala K, Opuwari CS. A review on the impact of oxidative stress and medicinal plants on Leydig cells. Antioxidants. 2023; 12: 1559.

[41] Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D, et al. Oxidative stress, aging, and diseases. Clinical Interventions in Aging. 2018; 13: 757–772.

[42] Salmon AB. Beyond Diabetes: Does Obesity-Induced Oxidative Stress Drive the Aging Process? Antioxidants (Basel). 2016; 5: 24.

[43] Ye J, Luo D, Xu X, Sun M, Su X, Tian Z, et al. Metformin improves fertility in obese males by alleviating oxidative stress-induced blood-testis barrier damage. Oxidative Medicine and Cellular Longevity. 2019; 2019: 9151067.

[44] Schumacher B, Pothof J, Vijg J, Hoeijmakers JHJ. The central role of DNA damage in the ageing process. Nature. 2021; 592: 695–703.

[45] Su X, Lin D, Luo D, Sun M, Wang X, Ye J, et al. Cyclophilin D participates in the inhibitory effect of high‐fat diet on the expression of steroidogenic acute regulatory protein. Journal of Cellular and Molecular Medicine. 2019; 23: 6859–6871.

[46] Shim M, Bang WJ, Oh CY, Lee YS, Cho JS. Androgen deprivation therapy and risk of cognitive dysfunction in men with prostate cancer: is there a possible link? Prostate International. 2022; 10: 68–74.

[47] Pettigrew JA, Novick AM. Hypoactive sexual desire disorder in women: physiology, assessment, diagnosis, and treatment. Journal of Midwifery & Women’s Health. 2021; 66: 740–748.

[48] Yang HJ, Kim KH, Kim DS, Lee CH, Jeon YS, Shim SR, et al. The effect of testosterone replacement on sexual function in the elderly: a systematic review and meta-analysis. The World Journal of Men’s Health. 2023; 41: 861.

[49] Lispi M, Drakopoulos P, Spaggiari G, Caprio F, Colacurci N, Simoni M, et al. Testosterone serum levels are related to sperm DNA fragmentation index reduction after FSH administration in males with idiopathic infertility. Biomedicines. 2022; 10: 2599.

[50] Kaufman J, Lapauw B, Mahmoud A, T’Sjoen G, Huhtaniemi IT. Aging and the male reproductive system. Endocrine Reviews. 2019; 40: 906–972.

[51] Xia K, Yu J, Liu G, Chen H, Ge R, Deng C. Aging and male hypogonadism. Frontiers in Endocrinology. 2023; 14: 1207907.

[52] Ide H. The impact of testosterone in men’s health. Endocrine Journal. 2023; 70: 655–662.

[53] Jeremy M, Gurusubramanian G, Roy VK. Vitamin D3 regulates apoptosis and proliferation in the testis of D galactose induced aged rat model. Scientific Reports. 2019; 9: 14103.

[54] Kaufman J, Lapauw B, Mahmoud A, T’Sjoen G, Huhtaniemi IT. Aging and the male reproductive system. Endocrine Reviews. 2019; 40: 906–972.

[55] Rodprasert W, Toppari J, Virtanen HE. Environmental toxicants and male fertility. Best Practice & Research Clinical Obstetrics & Gynaecology. 2023; 86: 102298.

[56] Guarnotta V, Amodei R, Frasca F, Aversa A, Giordano C. Impact of chemical endocrine disruptors and hormone modulators on the endocrine system. International Journal of Molecular Sciences. 2022; 23: 5710.

[57] Dutta S, Sengupta P, Bagchi S, Chhikara BS, Pavlík A, Sláma P, et al. Reproductive toxicity of combined effects of endocrine disruptors on human reproduction. Frontiers in Cell and Developmental Biology. 2023; 11: 1162015.

[58] Tarapore P, Ouyang B. Perfluoroalkyl chemicals and male reproductive health: do PFOA and PFOS increase risk for male infertility? International Journal of Environmental Research and Public Health. 2021; 18: 3794.

[59] Selvaraju V, Baskaran S, Agarwal A, Henkel R. Environmental contaminants and male infertility: effects and mechanisms. Andrologia. 2021; 53: e13646.

[60] Lokeshwar SD, Patel P, Fantus RJ, Halpern J, Chang C, Kargi AY, et al. Decline in serum testosterone levels among adolescent and young adult men in the USA. European Urology Focus. 2021; 7: 886–889.

[61] Pallotti F, Pelloni M, Gianfrilli D, Lenzi A, Lombardo F, Paoli D. Mechanisms of testicular disruption from exposure to bisphenol A and phtalates. Journal of Clinical Medicine. 2020; 9: 471.

[62] Rodprasert W, Toppari J, Virtanen HE. Endocrine disrupting chemicals and reproductive health in boys and men. Frontiers in Endocrinology. 2021; 12: 706532.

[63] Obukohwo OM, Benneth BA, Simon OI, Oghenetega OB, Victor E, Faith FY, et al. Testosterone: the male sex hormone. 2023; 80: 11.

[64] Duca Y, Aversa A, Condorelli RA, Calogero AE, La Vignera S. Substance abuse and male hypogonadism. Journal of Clinical Medicine. 2019; 8: 732.

[65] Katragadda V, Adem M, Mohammad RA, Sri Bhasyam S, Battini K. Testosterone recuperates deteriorated male fertility in cypermethrin intoxicated rats. Toxicological Research. 2021; 37: 125–134.

[66] Kanabar R, Mazur A, Plum A, Schmied J. Correlates of testosterone change as men age. The Aging Male. 2022; 25: 29–40.

[67] Corona G, Filippi S, Comelio P, Bianchi N, Frizza F, Dicuio M, et al. Sexual function in men undergoing androgen deprivation therapy. International Journal of Impotence Research. 2021; 33: 439–447.

[68] Vescini F, Chiodini I, Falchetti A, Palermo A, Salcuni AS, Bonadonna S, et al. Management of osteoporosis in men: a narrative review. International Journal of Molecular Sciences. 2021; 22: 13640.

[69] Zhang Z, Kang D, Li H. The effects of testosterone on bone health in males with testosterone deficiency: a systematic review and meta-analysis. BMC Endocrine Disorders. 2020; 20: 33.

[70] Ng Tang Fui M, Hoermann R, Bracken K, Handelsman DJ, Inder WJ, Stuckey BGA, et al. Effect of testosterone treatment on bone microarchitecture and bone mineral density in men: a 2-year RCT. The Journal of Clinical Endocrinology & Metabolism. 2021; 106: e3143–e3158.

[71] Yeap BB, Marriott RJ, Antonio L, Raj S, Dwivedi G, Reid CM, et al. Associations of serum testosterone and sex hormone–binding globulin with incident cardiovascular events in middle-aged to older men. Annals of Internal Medicine. 2022; 175: 159–170.

[72] Zhang X, Huang K, Saad F, Haider KS, Haider A, Xu X. Testosterone therapy reduces cardiovascular risk among hypogonadal men: a prospective cohort study in Germany. Androgens: Clinical Research and Therapeutics. 2021; 2: 64–72.

[73] Welén K, Damber J. Androgens, aging, and prostate health. Reviews in Endocrine and Metabolic Disorders. 2022; 23: 1221–1231.

[74] Xia BW, Zhao SC, Chen ZP, Chen C, Liu TS, Yang F, et al. Relationship between serum total testosterone and prostate volume in aging men. Scientific Reports. 2021; 11: 14122.

[75] Pillerová M, Borbélyová V, Pastorek M, Riljak V, Hodosy J, Frick KM. Molecular actions of sex hormones in the brain and their potential treatment use in anxiety disorders. Frontiers in Psychiatry. 2022; 13: 972158.

[76] Cai Z, Li H. An updated review: androgens and cognitive impairment in older men. Frontiers in Endocrinology. 2020; 11: 586909.

[77] Hauger RL, Saelzler UG, Pagadala MS, Panizzon MS. The role of testosterone, the androgen receptor, and hypothalamic–pituitary–gonadal axis in depression in ageing men. Reviews in Endocrine and Metabolic Disorders. 2022; 23: 1259–1273.

[78] Nguyen Hoai B, Hoang L, Nguyen Cao T, Pham Minh Q, A. Jannini E. Testosterone and aging male, a perspective from a developing country. The Aging Male. 2023; 26: 2223712.

[79] Jørgensen PL, Kreiberg M, Jørgensen N, Juul A, Oturai PS, Dehlendorff C, et al. Effect of 12-months testosterone replacement therapy on bone mineral density and markers of bone turnover in testicular cancer survivors—results from a randomized double-blind trial. Acta Oncologica. 2023; 62: 689–695.

[80] Siltari A, Murtola TJ, Kausz J, Talala K, Taari K, Tammela TL, et al. Testosterone replacement therapy is not associated with increased prostate cancer incidence, prostate cancer-specific, or cardiovascular disease-specific mortality in Finnish men. Acta Oncologica. 2023; 62: 1898–1904.

[81] Li JY, Li XY, Li M, Zhang GK, Ma FL, Liu ZM, et al. Decline of serum levels of free testosterone in aging healthy Chinese men. The Aging Male. 2005; 8: 203–206.

[82] Kreiberg M, Jørgensen N, Juul A, Lauritsen J, Oturai P, Helge JW, et al. A randomized double-blind single center study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention). Clinical Genitourinary Cancer. 2022; 20: 404–414.

[83] White WB, Dobs A, Carson C, DelConte A, Khera M, Miner M, et al. Effects of a novel oral testosterone undecanoate on ambulatory blood pressure in hypogonadal men. Journal of Cardiovascular Pharmacology and Therapeutics. 2021; 26: 630–637.

[84] Barnouin Y, Armamento-Villareal R, Celli A, Jiang B, Paudyal A, Nambi V, et al. Testosterone replacement therapy added to intensive lifestyle intervention in older men with obesity and hypogonadism. The Journal of Clinical Endocrinology & Metabolism. 2021; 106: e1096–e1110.

[85] Pencina KM, Travison TG, Artz AS, Lincoff AM, Nissen SE, Flevaris P, et al. Efficacy of testosterone replacement therapy in correcting anemia in men with hypogonadism. JAMA Network Open. 2023; 6: e2340030.

[86] Hinchely Ebdrup N, Hohwü L, Bay B, Obel C, Knudsen UB, Kesmodel US. Long-term growth in offspring of infertile parents: a 20-year follow-up study. Acta Obstetricia et Gynecologica Scandinavica. 202; 100: 1849–1857.

[87] Jung SJ, Park EO, Chae SW, Lee SO, Kwon JW, You JH, et al. Effects of unripe black raspberry extract supplementation on male climacteric syndrome and voiding dysfunction: a pilot, randomized, double-blind, placebo-controlled trial. Nutrients. 2023; 15: 3313.

[88] Smith SJ, Lopresti AL, Teo SYM, Fairchild TJ. Examining the effects of herbs on testosterone concentrations in men: a systematic review. Advances in Nutrition. 2021; 12: 744–765.

[89] Zhang Q, Yang C, Zhang M, Lu X, Cao W, Xie C, et al. Protective effects of ginseng stem-leaf saponins on D-galactose-induced reproductive injury in male mice. Aging. 2021; 13: 8916–8928.

[90] Sengupta P, Roychoudhury S, Nath M, Dutta S. Oxidative stress and idiopathic male infertility. Advances in Experimental Medicine and Biology. 2022; 62: 181–204.

[91] Agarwal A, Baskaran S, Parekh N, Cho C, Henkel R, Vij S, et al. Male oxidative stress infertility (MOSI): proposed terminology and clinical practice guidelines for management of idiopathic male infertility. World Journal of Men’s Health. 2021; 397: 319–333.

[92] Lai TC, Roychoudhury S, Cho C. Oxidative stress and varicocele-associated male infertility. Advances in Experimental Medicine and Biology. 2022; 42: 205–235.

[93] Chen G, Kathrins M, Ohlander S, Niederberger C. Medical management of male infertility: now and future. Current Opinion in Urology. 2023; 33: 10–15.

[94] Song J, Khera M. Current concepts, therapies, and recommendations to assist fertility outcomes in male patients with spinal cord injury. F&S Reviews. 2023; 4: 142–151.

[95] Guo J, Wang F, Zhou Q, Geng Q, Gao Q, Zhang R, et al. Safety and efficacy of traditional Chinese medicine, Qiaoshao formula, combined with dapoxetine in the treatment of premature ejaculation: an open-label, real-life, retrospective multicentre study in Chinese men. Andrologia. 2021; 53: e13915.

[96] Fode M, Krogh-Jespersen S, Brackett NL, Ohl DA, Lynne CM, Sønksen J. Male sexual dysfunction and infertility associated with neurological disorders. Asian Journal of Andrology. 2012; 14: 61–68.

[97] Sønksen J, Ohl DA. Penile vibratory stimulation and electroejaculation in the treatment of ejaculatory dysfunction. International Journal of Andrology. 2002; 25: 324–332.

[98] Li Y, Peng Q, Shang J, Dong W, Wu S, Guo X, et al. The role of taurine in male reproduction: physiology, pathology and toxicology. Frontiers in Endocrinology. 2023; 14: 1017886.

[99] Qamar AY, Naveed MI, Raza S, Fang X, Roy PK, Bang S, et al. Role of antioxidants in fertility preservation of sperm—a narrative review. Animal Bioscience. 2023; 36: 385–403.

[100] Kooshesh L, Nateghian Z, Aliabadi E. Evaluation of L-carnitine potential in improvement of male fertility. Journal of Reproduction & Infertility. 2023; 24: 69–84.

[101] Barbonetti A, Tienforti D, Castellini C, Giulio FD, Muselli M, Pizzocaro A, et al. Effect of antioxidants on semen parameters in men with oligo‐astheno‐teratozoospermia: a network meta-analysis. Andrology. 2024; 12: 538–552.

[102] Li X, Zhang B, Yang H, Zhang L, Lou H, Zheng S. The emergence of natural products as potential therapeutics for male infertility. To be published in Andrology. 2024. [Preprint].